About this trial
Lung cancer is the leading course of cancer related deaths world-wide. Lung cancer screening will increase the number of small lung lesion in need of biopsy to confirm the diagnosis. Obtaining lung biopsies with a bronchoscopy has the lowest risk of complications (1-2%) compared to other modalities such as transthoracic needle biopsy (20%), however diagnostic yield needs improvement. Currently a diagnosis is established in 50- 70% of the bronchoscopic procedures depending on the step-up. One way to improve the yield would be by using a cryo probe through the bronchoscope which freezes a small part of the lung for extraction, and thereby provides larger biopsies for examination. This will increase the chances of obtaining sufficient material from a small lesion to determine the diagnosis.
The DR CRYO study will compare cryo biopsies to forceps biopsies for the diagnosis of peripheral lung lesions.
We hope that the cryo biopsies can improve the diagnostic capabilities of bronchoscopy and provide better biopsies for tumor marker analyses. The project is relevant both for patients undergoing diagnostic work-up for lung cancer in early stages .
Eligibility criteria
Qualifiers
- Patients undergoing diagnostic work-up for lung cancer due to a lung lesion surrounded by normal lung tissue (identified by CT)
Age 18 or above
Bronchoscopy with planned forceps sampling from the lesion
Disqualifiers
- Pregnancy
Not able to provide informed consent.
Trial design
Treatments tested in this trial
- forceps biopsies
- Cryo biosies
Treatment groups
Sponsors and collaborators
Odense University Hospital
Lead sponsor
University of Southern Denmark
Collaborator